Literature DB >> 32473227

Unique skeletal manifestations in patients with Primrose syndrome.

Veronica Arora1, Eyby Leon2, Jullianne Diaz2, Hanne Buciek Hove3, Daniel Rocha Carvalho4, Kenji Kurosawa5, Naoto Nishimura5, Gen Nishimura6, Renu Saxena7, Carlos Ferreira8, Ratna Dua Puri7, Ishwar C Verma9.   

Abstract

Primrose syndrome (OMIM 259050) is a rare disorder characterised by macrocephaly with developmental delay, a recognisable facial phenotype, altered glucose metabolism, and other features such as sensorineural hearing loss, short stature, and calcification of the ear cartilage. It is caused by heterozygous variants in ZBTB20, a member of the POK family of transcription repressors. Recently, this gene was shown to have a role in skeletal development through its action on chondrocyte differentiation by repression of SOX9. We describe five unrelated patients with Primrose syndrome and distinct skeletal features including multiple Wormian bones, platybasia, bitemporal bossing, bathrocephaly, slender bones, epiphyseal and spondylar dysplasia. The radiological abnormalities of the skull and the epiphyseal dysplasia were the most consistent findings. This novel constellation of skeletal features expands the phenotypic spectrum of the disorder.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32473227      PMCID: PMC9445699          DOI: 10.1016/j.ejmg.2020.103967

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.465


  9 in total

Review 1.  Refining the Primrose syndrome phenotype: A study of five patients with ZBTB20 de novo variants and a review of the literature.

Authors:  Ruth Cleaver; Jonathan Berg; Emily Craft; Alison Foster; Richard J Gibbons; Emma Hobson; Katherine Lachlan; Swati Naik; Julian R Sampson; Saba Sharif; Sarah Smithson; Michael J Parker; Katrina Tatton-Brown
Journal:  Am J Med Genet A       Date:  2019-01-13       Impact factor: 2.802

2.  Novel de novo mutation in ZBTB20 in primrose syndrome in boy with short stature.

Authors:  Sigrún Grímsdóttir; Hanne B Hove; Sven Kreiborg; Jakob Ek; Anders Johansen; Tron A Darvann; Nuno V Hermann
Journal:  Clin Dysmorphol       Date:  2019-01       Impact factor: 0.816

3.  Zbtb20 regulates the terminal differentiation of hypertrophic chondrocytes via repression of Sox9.

Authors:  Guangdi Zhou; Xuchao Jiang; Hai Zhang; Yinzhong Lu; Anjun Liu; Xianhua Ma; Guan Yang; Rui Yang; Hongxing Shen; Jianming Zheng; Yiping Hu; Xiao Yang; Weiping J Zhang; Zhifang Xie
Journal:  Development       Date:  2015-01-15       Impact factor: 6.868

4.  Additional features of unique Primrose syndrome phenotype.

Authors:  Daniel Rocha Carvalho; Carlos Eduardo Speck-Martins
Journal:  Am J Med Genet A       Date:  2011-05-12       Impact factor: 2.802

5.  Mutations in ZBTB20 cause Primrose syndrome.

Authors:  Viviana Cordeddu; Bert Redeker; Emilia Stellacci; Aldo Jongejan; Alessandra Fragale; Ted E J Bradley; Massimiliano Anselmi; Andrea Ciolfi; Serena Cecchetti; Valentina Muto; Laura Bernardini; Meron Azage; Daniel R Carvalho; Alberto J Espay; Alison Male; Anna-Maja Molin; Renata Posmyk; Carla Battisti; Alberto Casertano; Daniela Melis; Antoine van Kampen; Frank Baas; Marcel M Mannens; Gianfranco Bocchinfuso; Lorenzo Stella; Marco Tartaglia; Raoul C Hennekam
Journal:  Nat Genet       Date:  2014-07-13       Impact factor: 38.330

6.  Clinical and functional characterization of two novel ZBTB20 mutations causing Primrose syndrome.

Authors:  Emilia Stellacci; Katharina Steindl; Pascal Joset; Laura Mercurio; Massimiliano Anselmi; Serena Cecchetti; Laura Gogoll; Markus Zweier; Annette Hackenberg; Gianfranco Bocchinfuso; Lorenzo Stella; Marco Tartaglia; Anita Rauch
Journal:  Hum Mutat       Date:  2018-05-17       Impact factor: 4.878

7.  A slowly progressive degenerative condition characterized by mental deficiency, wasting of limb musculature and bone abnormalities, including ossification of the pinnae.

Authors:  D A Primrose
Journal:  J Ment Defic Res       Date:  1982-06

8.  A novel microdeletion syndrome at 3q13.31 characterised by developmental delay, postnatal overgrowth, hypoplastic male genitals, and characteristic facial features.

Authors:  Anna-Maja Molin; J Andrieux; D A Koolen; V Malan; M Carella; L Colleaux; V Cormier-Daire; A David; N de Leeuw; B Delobel; B Duban-Bedu; R Fischetto; F Flinter; S Kjaergaard; F Kok; A C Krepischi; C Le Caignec; C Mackie Ogilvie; S Maia; M Mathieu-Dramard; A Munnich; O Palumbo; F Papadia; R Pfundt; W Reardon; A Receveur; M Rio; L Ronsbro Darling; C Rosenberg; J Sá; L Vallee; C Vincent-Delorme; L Zelante; M-L Bondeson; G Annerén
Journal:  J Med Genet       Date:  2011-12-17       Impact factor: 6.318

9.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.